REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
23 hedge funds and large institutions have $13M invested in REVIVA PHARMA HLDGS INC in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0% more funds holding
Funds holding: 23 → 23 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.05% less ownership
Funds ownership: 0.64% → 0.59% (-0.05%)
7% less call options, than puts
Call options by funds: $9.37M | Put options by funds: $10.1M
16% less capital invested
Capital invested by funds: $15.4M → $13M (-$2.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$603K |
| 2 |
ECM
EMC Capital Management
Houston,
Texas
|
+$536K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$239K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$208K |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.04M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$343K |
| 3 |
Renaissance Technologies
New York
|
-$207K |
| 4 |
Millennium Management
New York
|
-$170K |
| 5 |
VF
Virtu Financial
New York
|
-$108K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
26
Virtu Financial
New York
| – | -$108K | -922 | Closed |
|
27
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$78K | -669 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$65.1K | -555 | Closed |
|
RVPH Hedge Fund Activity: Q3 2023 in Review
23 of the 6,304 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q3 2023, worth a combined $13M — down 16% from $15.4M a quarter earlier.
Fund positioning in RVPH was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 8 added to existing stakes and 7 trimmed.
The largest buyer was Group One Trading, opening a new position worth an estimated $603K. The largest seller was Armistice Capital, cutting an estimated $1.04M.
- 23 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $13M of REVIVA PHARMA HLDGS INC stock for Q3 2023, down 16% quarter-over-quarter.
- 5 funds opened new REVIVA PHARMA HLDGS INC positions in Q3 2023 and 5 closed out, a net change of 0 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q3 2023 was Group One Trading, an estimated $603K added.
- The largest REVIVA PHARMA HLDGS INC seller in Q3 2023 was Armistice Capital, an estimated $1.04M sold.
Based on aggregated 13F filings for Q3 2023.